FBR


FBR Remains Sidelined on AT&T Inc. (T) Following 2Q:16 Results

In a research report issued today, FBR analyst David Dixon reiterated a Market Perform rating on shares of AT&T Inc. (NYSE:T), while raising the …

2Q16 Review: FBR Analyst Weighs In on Pandora Media Inc (P)

In a research report sent to investors today, FBR analyst Barton Crockett reiterated an Outperform rating on shares of Pandora Media Inc (NYSE:P), with …

FBR Slashes Price Target For Galena Biopharma Inc (GALE); Reiterates Positive Stance

FBR analyst Vernon Bernardino was out today with a mix report on shares of Galena Biopharma Inc (NASDAQ:GALE), reiterating an Outperform rating while slashing the …

FBR Analyst Cuts Price Target for Netflix, Inc. (NFLX); Remains Neutral

Neflix, Inc. (NASDAQ:NFLX) just took a huge dive after releasing its quarterly earnings, however, FBR analyst Barton Crockett isn’t giving up on the company …

FBR Analyst Raises Estimates for Netflix, Inc. (NFLX) Ahead of 2Q:16 Earnings

FBR analyst Barton Crockett offers an overview of what to expect from streaming video giant Netflix, Inc.(NASDAQ:NFLX) ahead of its second-quarter earnings on Monday, July 18.

FBR Slashes Price Target on CytRx Corporation (CYTR) Following Clinical Trial Setback

Shares of CytRx Corporation (NASDAQ:CYTR) are collapsing, down 66% at time of writing, after the company provided initial results from its Phase III study with aldoxorubicin …

FBR Weighs In on Two Falling Biotechs: Juno Therapeutics Inc (JUNO), Kite Pharma Inc (KITE)

FBR analyst Edward White is weighing in on biotech firms Juno Therapeutics Inc (NASDAQ:JUNO) and Kite Pharma Inc (NASDAQ:KITE), as both stocks tumbled sharply today following FDA …

FBR Reiterates Outperform on Advaxis, Inc. (ADXS) Following SPA Agreement With FDA

In a research report published on Thursday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Advaxis, Inc. (NASDAQ:ADXS) with a price …

FBR Weighs In On Galena Biopharma Inc (GALE) Following Clinical Setback

FBR analyst Vernon Bernardino weighed in on Galena Biopharma Inc (NASDAQ:GALE), after the company announced that its Independent Data Monitoring Committee completed an interim analysis …

FBR Analyst Weighs In on Canadian Solar Inc. (CSIQ) Following Recent Tornado Damage

FBR analyst Carter Driscoll weighed in with a few insights on Canadian Solar Inc. (NASDAQ:CSIQ), after the company disclosed that a tornado damaged its Chinese solar cell …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts